Decreased Susceptibility to Fatty Acid–Induced Peripheral Tissue Insulin Resistance in Women
Open accessAbstract
Elevation of plasma nonesterified fatty acid (NEFA) levels has been shown in various studies to induce peripheral tissue insulin resistance and impair the suppression of endogenous glucose production (EGP). These studies have been conducted predominantly in men. We compared the effects of elevated plasma NEFA levels on basal and insulin-stimulated glucose metabolism in 8 normal women (age 42 ± 8 years [mean ± SD], BMI 25 ± 3 kg/m2) and 10 normal men (35 ± 6 years, 24 ± 3 kg/m2). Each subject underwent two 5-h 80 mU · m–2 · min–1 hyperinsulinemic-euglycemic clamps with measurement of glucose kinetics (intravenous [3-3H]glucose) and substrate oxidation. Plasma NEFA levels were elevated in one study for 3 h before and during the clamp (∼1 mmol/l in both groups) by infusion of 20% Intralipid (60 ml/h) and heparin (900 U/h). In the control studies, the men and women had similar insulin-stimulated glucose disposal rates (Rd) and substrate oxidation rates. In the men, elevated NEFA levels decreased insulin-stimulated glucose Rd during the final 40 min of the clamp by 23% (P < 0.001). By contrast, no significant change in glucose Rd was found in the women (control 10.4 ± 1.1, lipid study 9.9 ± 1.3 mg · kg–1 · min–1). Glucose Rd was also unchanged in six women studied at a lower insulin dose (40 mU · m–2 · min–1). During the last 40 min of the high–insulin dose clamps with elevated NEFA, glucose oxidation was decreased by 33% in the men (P < 0.001) and by 23% in the women (P < 0.02). Nonoxidative glucose Rd at this time was decreased by 15% in the men (P = 0.02) but was not significantly affected in women. Basal EGP was unaffected by elevation of plasma NEFA levels in both groups. Suppression of EGP during the glucose clamps, however, was impaired. At the insulin infusion rate used, the magnitude of this defect was comparable in men and women. In summary, our findings suggest that although the effects on EGP appear comparable, the inhibitory effects of NEFA on peripheral tissue insulin sensitivity are observed in men but cannot be demonstrated in women.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Women are resistant to FFA-induced insulin resistance.
“In fact, women are resistant to FFA-induced insulin resistance [34].”
From Sex differences in metabolic homeostasis, diabetes, and obesity (2015) · cites this paper as [34]
The Discussion reports that elevated fatty acids did not impair insulin-stimulated peripheral glucose uptake in the women studied, unlike in men. But it also reports impaired suppression of endogenous glucose production in women, so the unqualified claim that women are resistant to FFA-induced insulin resistance is broader than the finding. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 42 · Cited by 162
- Authors
- Frias, J. P., Macaraeg, G. B., Ofrecio, J., Yu, J. G., Olefsky, J. M., & Kruszynska, Y. T.
- Affiliations
- Department of Endocrinology and Metabolism, University of California–San Diego, Veterans Affairs Medical Center, La Jolla, California
- University of California San Diego (US)
- ORCID
- Olefsky, Jerrold M.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2001-06-01
- Volume
- 50
- Issue
- 6
- Pages
- 1344-1350
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2125528261
- Cited by
- 162
- References
- 42
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 11 · 2023: 13 · 2022: 7 · 2021: 6 · 2020: 9 · 2019: 10 · 2018: 8 · 2017: 8 · 2016: 7 · 2015: 6 · 2014: 6 · 2013: 7 · 2012: 5
- FWCI
- 3.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-33649)
- National Center for Research Resources (M-01RR00827, M01RR000827)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Keywords
- insulin resistance, free fatty acids, fatty acid infusion, sex differences, women, peripheral glucose metabolism, insulin-stimulated glucose disposal, substrate oxidation, glucose oxidation, nonoxidative glucose disposal, endogenous glucose production, hyperinsulinemic-euglycemic clamp, Intralipid, glucose kinetics, insulin sensitivity
- MeSH terms
- Adult, Blood Glucose, Drug Resistance, Fatty Acids, Fatty Acids, Nonesterified, Female, Glucose, Humans, Insulin, Insulin Resistance, Male, Middle Aged, Osmolar Concentration, Oxidation-Reduction, Sex Characteristics, Triglycerides, Glucose Clamp Technique
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review